Huaren Pharmaceutical Co., Ltd. (SHE:300110)

China flag China · Delayed Price · Currency is CNY
3.240
-0.120 (-3.57%)
Apr 9, 2026, 3:04 PM CST
Market Cap3.83B +4.2%
Revenue (ttm)1.26B -15.9%
Net Income-1.41B
EPS-1.19
Shares Out1.18B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume65,038,800
Average Volume36,636,071
Open3.390
Previous Close3.360
Day's Range3.220 - 3.460
52-Week Range2.710 - 3.750
Beta0.42
RSI49.95
Earnings DateApr 24, 2026

About Huaren Pharmaceutical

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, ant... [Read more]

Sector Healthcare
Founded 1998
Employees 2,491
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300110
Full Company Profile

Financial Performance

Financial Statements